Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
03/2010
03/25/2010WO2010032856A1 Nitrogen-containing heterocyclic compound and use of same
03/25/2010WO2010032704A1 Pharmaceutical preparation comprising micro-rna-143 derivative
03/25/2010WO2010032461A1 Nitrogen-containing fused ring compound
03/25/2010WO2010032154A2 Method for the diagnosis of proventricular dilatation disease and kit thereof
03/25/2010WO2010031819A1 Treating inflammation and inflammatory pain in mucosa using mucosal prolonged release bioadhesive therapeutic carriers.
03/25/2010WO2010031809A1 Use of azaperone for reducing antibiotic usage
03/25/2010WO2010031577A1 Use of bradykinin b1 receptor antagonists in intestinal fibrosis treatment
03/25/2010WO2010031521A2 Intestinal treatment
03/25/2010WO2010013078A3 Pyrrolidinyl-alkyl-amide derivatives their preparation and their therapeutic application as ccr3 receptor ligands
03/25/2010WO2010008491A3 Lactose compositions with decreased lactose content
03/25/2010WO2009141533A3 Pyrrole derivatives, preparation of same and therapeutic application thereof as cannabinoid cb1 receptor antagonists
03/25/2010WO2009111083A3 In vivo temporal control of activ at able matrix- degrading enzymes
03/25/2010US20100076068 Aminoalcohol Derivatives and Their Therapeutic Use
03/25/2010US20100076044 Therapeutic agent for inflammatory bowel disease and tnf-alpha production inhibitor
03/25/2010US20100076025 Process for solvent removal from omeprazole salts
03/25/2010US20100075986 Oxophenyl-Cyclohexyl-Propanolamine Derivatives, Production And Use Thereof In Therapeutics
03/25/2010US20100075963 Pharmaceutically Active Benzensulphonyl-Indols
03/25/2010US20100075932 Novel salicylic anilides
03/25/2010US20100075931 Substituted oxazole ketone modulators of fatty acid amide hydrolase
03/25/2010US20100075910 Synthetic peptide amides and dimeric forms thereof
03/25/2010US20100075900 Use of Nutritional Compositions for Preventing Disorders
03/25/2010US20100074978 Method of treatment and prevention of metabolic and digestion disorders and of pathological states associated therewith and products used therein
03/25/2010US20100074975 Pharmaceutical composition for the prevention and treatment of liver disease comprising a lonicera caerulea L. Var. Edulis extract
03/25/2010US20100074954 Adsorbent for oral administration
03/25/2010US20100074937 Polyanhydrides with therapeutically useful degradation products
03/25/2010US20100074921 Carrier
03/25/2010US20100074887 Methods for Treating and Diagnosing Fibrotic and Fibroproliferative Diseases
03/25/2010US20100074878 Probiotic bacterium: lactobacillus fermentum
03/25/2010US20100074871 Probiotic infant products
03/25/2010US20100074870 Probiotic infant products
03/25/2010US20100074852 Use of cis-epoxyeicosatrienoic acids and inhibitors of soluble epoxide hydrolase to treat conditions mediated by pbr, cb2, and nk2 receptors
03/25/2010CA2737828A1 Intestinal treatment
03/25/2010CA2737295A1 Method for the diagnosis of proventricular dilatation disease and kit thereof
03/25/2010CA2733420A1 Use of azaperone for reducing antibiotic usage
03/25/2010CA2732893A1 Treating inflammation and inflammatory pain in mucosa using mucosal prolonged release bioadhesive therapeutic carriers.
03/24/2010EP2166095A2 Antisense oligonucleotides capable of inhibiting the formation of capillary tubes in endothelial cells
03/24/2010EP2166087A2 FAD4, FAD5, FAD5-2 et FAD6, fatty acid desaturase family members and uses thereof
03/24/2010EP2165715A1 Therapeutic agent for cancer, and method for treatment of cancer
03/24/2010EP2165706A1 Treating Inflammatory Pain in Mucosa of the Oral Cavity Using Mucosal Prolonged Release Bioadhesive Therapeutic Carriers.
03/24/2010EP2165610A1 Tympanites ventriculi-controlling agent for ruminant animals
03/24/2010EP2165609A1 Rumen fermentation improving agent
03/24/2010EP2164848A1 Polymorphic form of granisetron base, methods for obtaining it and formulation containing it
03/24/2010EP2164532A2 Use of a haemoglobin for the preparation of dressings and resulting dressings
03/24/2010EP1389110B1 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
03/24/2010EP1009399B1 Gaba analogs to prevent and treat gastrointestinal damage
03/24/2010CN101679476A 23-substituted bile acids as TGR5 modulators and methods of use thereof
03/24/2010CN101679445A Pyrimidinedione derivatives and methods of use thereof
03/24/2010CN101679444A Xanthine compounds having a positive allosteric gabab receptor modulator effect
03/24/2010CN101679433A Novel adenine compound
03/24/2010CN101679355A benzimidazole cannabinoid agonists
03/24/2010CN101679317A Novel 1,2,3,4-tetrahydroquinoxaline derivative which has, as substituent, phenyl group having sulfonic acid ester structure or sulfonic acid amide structure introduced therein and has glucocorticoid r
03/24/2010CN101679298A fused bicyclic heteroaryl derivatives
03/24/2010CN101679273A 1-substituted tetrahydroisoquinoline compound
03/24/2010CN101679271A Quinoline derivatives, pharmaceutical compositions comprising them, and their use in treating central nervous system and peripheral diseases
03/24/2010CN101679248A Indole derivative having cpla2 inhibitory activity, use of the same and method for producing the same
03/24/2010CN101678217A Composition for treatment of xerostomy or dry mouth
03/24/2010CN101678054A Probiotics in a pre- and/or post surgical environment
03/24/2010CN101678024A Buspirone for the treatment of nausea and vomiting
03/24/2010CN101677958A Oral pharmaceutical preparation for colon-specific delivery
03/24/2010CN101677932A Skin-lightening agent containing equol compound as active ingredient
03/24/2010CN101677597A Tympanites ventriculi-controlling agent for ruminant animals
03/24/2010CN101677596A Lumen fermentation improving agent
03/24/2010CN101676391A A system capable of stably expressing cell cycle factor FoxM1 and its medical use
03/24/2010CN101676298A 黑皮质素受体配体 Melanocortin receptor ligands
03/24/2010CN101676281A Benzo macrolide compound (3R)- des-O-methyllasiodiplodin, its derivatives and preparation method and use
03/24/2010CN101675990A Formula comprising pawpaw for treating duodenal ulcer
03/24/2010CN101675989A Qi-supplementing, spleen-invigorating, kidney-tonifying and blood-generating traditional Chinese medicine composition
03/24/2010CN101675987A Traditional Chinese medicine concentrated solution for treating liver and gall stone
03/24/2010CN101675984A A fumigating-washing agent for children
03/24/2010CN101675983A Warming and tonifying agent for qi-deficiency syndrome
03/24/2010CN101675977A Formula comprising black alum for treating hepatopathy
03/24/2010CN101675974A A formula of anti-diarrheal capsule
03/24/2010CN101675965A Formula comprising pinellia ternate for treating epigastric pain
03/24/2010CN101675955A A fresh pomegranate rind formula for treating chronic gastritis
03/24/2010CN101675954A Traditional Chinese medicine composition for treating abdominal pain and distension
03/24/2010CN101675951A Formula comprising artemisia capillaries for treating hepatopathy
03/24/2010CN101675947A Traditional Chinese medicine for treating gallstones
03/24/2010CN101675943A A formula for a traditional Chinese medicine health capsule and manufacturing technology
03/24/2010CN101675938A Preparation method and use of a novel peptide type immunizing agent whole-egg protein peptide
03/24/2010CN101675935A Use of ginsenoside compound
03/24/2010CN101675933A Use of ginsenoside compound
03/24/2010CN101675927A therapeutic molecules and methods-1
03/24/2010CN101675924A Application of ascaridol in preparing medicine for preventing helicobacter pylori and treating disease caused by helicobacter pylori
03/24/2010CN101675748A Novel tooth-protecting chewing gum
03/24/2010CN100595200C Compound of dehydrogenated cavidine group and application in medication
03/24/2010CN100594935C Antibodies that immunospecifically bind to trail receptors
03/24/2010CN100594930C Medicinal composition using anterior pituitary adrenal cortical extract as main component, and its preparation method and use
03/24/2010CN100594921C Traditional Chinese medicine compound preparations for treating chronic hepatitis B and cirrhosis
03/24/2010CN100594920C Kidney-replenishing sperm-supplementing granule
03/24/2010CN100594911C Medicine composition and use
03/24/2010CN100594909C Therapeutic agent for hemorrhoidal disease
03/24/2010CN100594908C Triamcinolone benetonide local film forming gel composition
03/24/2010CN100594903C HCV inhibiting bi-cyclic pyrimidines
03/24/2010CN100594898C Pharmaceutical composition of Silybin and preparation method thereof
03/24/2010CN100594897C Cannabinoid liquid formulations for mucosal amdinistration
03/24/2010CN100594891C Compound quassia drop pills for diminishing inflammation and its preparation method
03/24/2010CN100594890C Simotang drop pill and its preparation method
03/24/2010CN100594804C Compound rhodamine oil soft capsule and method for preparing the same
03/24/2010CN100594796C Sichuan fritillary bulb mint plum and its producing method
03/23/2010US7683164 Nucleic acid derivatives
1 ... 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 ... 1258